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Role of Janus Kinase 3 in Mast Cell-Mediated
Innate Immunity against Gram-Negative Bacteria
JAK3, are cytoplasmic protein tyrosine kinases (PTK)
that play pivotal roles in the initiation of cytokine-trig-
gered signaling events by activating the cytoplasmic
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Parker Hughes Institute (Ihle and Kerr, 1995). Among the four members of the
JAK family, JAK3 is abundantly expressed in lymphoid2665 Long Lake Road
St. Paul, Minnesota 55113 cells and plays an important role in normal lymphocyte
development and function (Buckley et al., 1997; Bunting
et al., 1999; Nosaka et al., 1995; Thomis et al., 1995;
Villa et al., 1996). We have recently shown that JAK3 isSummary
also a key regulator of IgE receptor-mediated mast cell
responses (Malaviya and Uckun, 1999; Malaviya et al.,Mast cells play a pivotal role in innate host immune
response to gram-negative bacteria. We report that 1999). Specifically, we found that JAK3 is activated upon
IgE receptor crosslinking in mast cells and JAK3/mastJanus kinase 3 plays a role in mast cell-mediated bac-
terial clearance and neutrophil recruitment by regulat- cells release substantially reduced amounts of inflam-
matory mediators upon IgE receptor crosslinking asing the release of tumor necrosis factor from mast
cells. The role of JAK3 in mast cell-facilitated neutro- compared to wild-type mast cells (Malaviya et al., 2000;
Malaviya and Uckun, 1999; Malaviya et al., 1999).phil recruitment and bacterial clearance was investi-
gated by comparing the neutrophil influxes and bacte- Whether JAK3 has any role in mast cell responses
against bacteria is currently unknown.rial clearance in mast cell-deficient W/Wv mice
reconstituted with JAK3/ or JAK/ mast cells. The The purpose of the present study was to evaluate if
JAK3 plays a regulatory role in mast cell-mediated in-neutrophil influx, bacterial clearance, and survival out-
come in W/Wv mice reconstituted with JAK3/ mast nate immunity against gram-negative bacteria. To this
end, we examined the roles of JAK3 in mast cell-medi-cells was better than in W/Wv mice reconstituted with
JAK3/ mast cells. These findings provide evidence ated bacterial clearance and neutrophil recruitment in
a well-characterized mouse model of E. coli-inducedthat JAK3 is a key regulator of mast cell-mediated
innate immunity against gram-negative bacteria. acute peritonitis (Malaviya and Abraham, 2000; Malaviya
et al., 1996). Our results show that JAK3 plays a pivotal
role in mast cell-mediated innate immunity by modulat-Introduction
ing the recruitment of neutrophils to the sites of infec-
tion. Specifically, JAK3-knockout mice exhibit a signifi-The physiologic functions of mast cells have been the
subject of intense research efforts in the field of innate cantly impaired efficiency to clear bacteria when
compared to wild-type mice. The impaired bacterialimmunity (Echtenacher et al., 1996; Malaviya and Abra-
ham, 1998; Malaviya et al., 1996; Maurer et al., 1998; clearance rate and neutrophil influx in JAK3-knockout
mice was due to a loss of the ability of JAK3-deficientProdeus et al., 1997). The abundant presence of mast
cells at the host/environment interface (e.g., skin; linings mast cells to release TNF in response to E .coli and their
reduced ability to kill phagocytized bacteria. Notably,of the gastrointestinal, respiratory, and urinary tracts),
common sites of bacterial entry, prompted the hypothe- reconstitution of mast cell-deficient WBB6F1-W/Wv
mice with JAK3/ mast cells, but not JAK3/ mastsis that these cells may play an important role in host
defense against bacterial infections. A number of stud- cells, improved their neutrophil response and ability to
clear bacteria in E. coli-induced acute peritonitis as wellies have confirmed that mast cells play a critical role in
host immune defense against gram-negative bacteria as their survival outcome after a systemic E. coli chal-
lenge. These findings provide experimental evidencethrough the release of tumor necrosis factor (TNF) 
(Echtenacher et al., 1996; Malaviya and Abraham, 1998; that JAK3 is a key regulator of mast cell-mediated innate
immunity to gram-negative bacteria.Malaviya et al., 1996; Maurer et al., 1998; Prodeus et al.,
1997). The release of this potent chemotactic cytokine
by mast cells is mediated through the direct interaction Results and Discussion
of FimH, an adhesion molecule present on the type 1
pili of most of the gram-negative bacteria (Escherichia JAK3 as a Regulator of Mast Cell TNF Response and
coli, Salmonella typhimurium, Klebsiella pneumoniae, Bactericidal Activity against Gram-Negative Bacteria
etc.), with the mast cell surface receptor, CD48 (Malaviya We previously demonstrated in a mouse model of bacte-
et al., 1999). However, very little is known about the rial peritonitis that mast cells participate in innate immu-
downstream events that follow the binding of bacteria nity against the gram-negative organisms by facilitating
and the nature of bacterial signals that culminate in the the recruitment of neutrophils to the sites of active bac-
release of TNF and bactericidal activity of mast cells. terial infection through the release of the chemotactic
Janus kinases (JAK), including JAK1, JAK2, Tyk, and cytokine TNF (Malaviya et al., 1996). In order to evaluate
the potential role of JAK3 in mast cell responses to
gram-negative bacteria, we first studied the in vitro ef-4Correspondence: rmalaviya2@ih.org
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WHI-P112, which does not inhibit JAK3, inhibited the E.
coli-induced in vitro TNF release from mast cells in a
concentration-dependent fashion. While it is possible
that an as yet unknown activity of WHI-P131 on enzymes
other than JAK3 contributed to the observed WHI-P131-
induced inhibition of E. coli-induced in vitro TNF re-
lease from mast cells, these results implicated JAK3 as
an important regulator of TNF release from mast cells.
Because of the inherent limitations of bioassays,
which rely on chemical inhibitors of enzymes, we sought
to further evaluate the role of JAK3 in mast cell-mediated
innate immunity against gram-negative bacteria using
genetic models. We first compared the E. coli-induced
in vitro TNF release from JAK3/ bone marrow mast
cells from wild-type mice to that from JAK3/ bone
marrow mast cells from JAK3-knockout mice. As shown
in Figure 1B, JAK3/ mast cells released 90% less
TNF after the E. coli challenge than JAK3/ mast cells.
Thus, JAK3 is a key regulator of E. coli-induced mast
cell TNF response.
In order to ascertain that the poor TNF response of
JAK3/ mast cells was not caused by poor recognition
and binding of bacteria in the absence of JAK3, we next
compared the expression levels of CD48, the mast cell
surface membrane receptor for bacterial FimH (Malaviya
et al., 1999), on mast cells from JAK3/ and JAK3/
mice. As shown in Figure 2, JAK3 deficiency (A and B)
was not associated with reduced expression of CD48
on the surface of mast cells (C and D). In accordance
with this observation, JAK3/ mast cells were as effi-
cient as JAK3/mast cells in binding the FimH-express-
ing E. coli ORN103(pSH2) (Figure 2E). Thus, the poor
TNF response of JAK3/ mast cells was not owing to
altered expression or function of the CD48 receptor.
Mast cells have the capacity to both phagocytize and
kill adherent E. coli. We therefore asked if the JAK3
deficiency of mast cells could impair their phagocytic
and/or bactericidal activity. Multiphoton confocal laser
scanning microscopy was used to evaluate the kinetics
of the uptake of FITC-labeled E. coli ORN103(pSH2) by
JAK3/ versus JAK3/ mast cells. As shown in Figure
3, E. coli were phagocytized within 10 min by JAK3/
(A) as well as JAK3/ (B) mast cells and destroyed
Figure 1. Effect of JAK3 Inhibition on E. coli-Induced TNF Release within 30 min after entry into the cytosol. Nevertheless,
by Mast Cells the destruction of phagocytized bacteria was slightly
(A) Mast cells cultured from the bone marrow cells of wild-type mice impaired in JAK3/ mast cells, as evidenced by a some-
were incubated with the indicated concentrations of JAK3 inhibitor what sluggish disappearance of some of the E. coli en-
(WHI-P131) or the control compound (WHI-P112) for 1 hr prior to tering the cytosol (Figure 3B). We next compared the
challenge with E. coli. Following incubation, cells were centrifuged
bactericidal activity of JAK3/ and JAK3/ mast cellsat 200g for 10 min, and extracellular TNF levels were quantitated.
using a quantitative assay for residual bacteria followingThe results are presented as the percent of control. The data points
represent the mean  SEM values (n  7). An asterisk indicates a 1 hr incubation. In accordance with the confocal im-
that p  0.05 compared to the control compound, WHI-P112. aging data, JAK3 deficiency of mast cells was associ-
(B) JAK3/ and JAK3/ mast cells were exposed to E. coli for 1 ated with a slightly impaired bactericidal activity (Figure
hr, and TNF levels in cell supernatants were quantitated. The data 4). This impairment of mast cell bactericidal activity was
points represent the mean SEM values (n 4–6). A double asterisk
statistically insignificant (percent reduction of viableindicates that p  0.001 compared to wild-type controls.
bacteria: 45  12% associated with JAK3/ mast cells
versus 25  8% associated with JAK3/ mast cells;
p  0.4).fects of WHI-P131 (Sudbeck et al., 1999), a rationally
designed and specific inhibitor of JAK3, on TNF release
from mast cells challenged with E. coli. WHI-P131 does JAK3 as a Regulator of Mast Cell-Mediated In Vivo
Clearance of Gram-Negative Bacterianot inhibit other mast cell tyrosine kinases such as SYK,
BTK, or LYN (Sudbeck et al., 1999). As shown in Figure As the JAK3 deficiency of mast cells was associated
with markedly reduced TNF release after exposure to1A, WHI-P131, but not the structurally related compound
JAK3 in Bacteria-Mediated Mast Cell Response
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Figure 2. Effect of JAK3 Deficiency on Mast
Cell Expression of CD48 and Its Function
(A and B) Cultured bone marrow-derived
mast cells from (A) JAK3/ and (B) JAK3/
mice were stained with a polyclonal anti-
JAK3 antibody (Santa Cruz) and labeled with
a fluorescein-labeled secondary antibody
visualized using a Nikon Diaphot microscope
equipped for epifluorescence. Images were
captured with a cooled CCD camera
(Princeton Instruments) with Metamorph soft-
ware (Universal Imaging). Exposure times for
fluorescent images are identical. Images
were processed using PhotoShop software
(Adobe Systems).
(C and D) Flow cytometric comparison of
CD48 receptor expression on (C) JAK3/
versus (D) JAK3/mast cells were performed
by labeling the cells with a CD48-specific an-
tibody and an FITC-labeled secondary an-
tibody.
(E) Monolayers of JAK3/ and JAK3/ mast
cells were exposed to bacteria for 30 min as
described in Experimental Procedures. The
number of adherent bacteria was counted un-
der a light microscope after staining the
slides with crystal violet. The results are pre-
sented as the total number of bound bacteria
per 50 mast cells. The data points represent
the mean  SEM values (n  3).
E. coli in vitro, we compared the TNF contents of the oxidase level for JAK3-knockout mice was substantially
lower than that for wild-type mice, consistent with aperitoneal lavage specimens of JAK3-knockout versus
wild-type mice following intraperitoneal inoculation with markedly impaired neutrophil influx. The role of JAK3 in
mast cell-facilitated neutrophil recruitment after a bacte-E. coli. The measured TNF contents were significantly
lower for JAK3-knockout mice as compared to wild- rial challenge was further investigated by comparing the
E. coli-induced neutrophil influxes in mast cell-deficienttype mice, indicating that JAK3 deficiency is associated
with a markedly reduced in vivo TNF release after bac- WBB6F1-W/Wv (W/Wv) mice, W/Wv mice reconstituted
with JAK3/ mast cells (W/Wv  JAK3/), and W/Wvterial challenge as well (Figure 5A). The observed reduc-
tion of TNF levels in the peritoneal lavage specimens mice reconstituted with JAK3/ mast cells (W/Wv 
JAK3/). To achieve reconstitution of W/Wv mice withof JAK3/ mice was not due to reduced numbers of
mast cells in the peritoneal cavities of JAK3/ mice. JAK3/ and JAK3/ mast cells, bone marrow-derived
cultured mast cells from JAK3/and JAK3/mice wereThe number of mast cells recovered from the peritoneum
of JAK3/ (0.53  0.09  106/peritoneum) and JAK3/ injected into the peritoneum of W/Wv mice (Figure 6A).
The number (Figure 6B) as well as the staining character-(0.56 0.08 106/peritoneum) mice was virtually identi-
cal. The residual TNF levels in the peritoneum of istics and granulation (Figure 6C) of mast cells from
W/Wv  JAK3/ and W/Wv JAK3/ mice were simi-JAK3/ mice following bacterial challenge likely stem
from the resident macrophages and recruited neutro- lar to those of mast cells from WBB6F1-/ (/)
mice (congenic controls), whereas no mast cells werephils (Zhang et al., 1992).
Mast cell-derived TNF has been implicated in neutro- detected in the peritoneal lavage specimens of W/Wv
mice. Peritoneal cells of recipient W/Wv mice were alsophil emigration to the sites of active infection (Malaviya
et al., 1996). Therefore, we next evaluated the neutrophil examined for differentiation of the injected bone mar-
row-cultured JAK3/ and JAK3/ mast cells into con-influx into the peritoneal cavity of JAK3-knockout versus
wild-type mice challenged with an intraperitoneal inocu- nective tissue-type mast cells by Avidin-FITC staining
(Malaviya et al., 1994). Avidin specifically binds to hepa-lum of E. coli by measuring the myeloperoxidase levels
in the cell lysates from their peritoneal lavage speci- rin in the granules of connective tissue-type mast cells
(Malaviya et al., 1994). The bone marrow-cultured mastmens. As shown in Figure 5B, the measured myeloper-
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Figure 3. Multiphoton Microscopy of Bacte-
ricidal Activity in Living Mast Cells
(A) JAK3/ mast cells.
(B) JAK3/ mast cells.
Mast cells adherent on vitronectin-coated
cover slips were exposed to FITC-labeled E.
coli ORN103(pSH2) under a humidified atmo-
sphere at 37	C and imaged by multiphoton
microscopy at 750 nm every 5 min for 2 hr.
As shown in (A) and (B), bacteria (asterisk)
bind to wild-type mast cells rapidly trans-
ported inside the cell and are destroyed
within 25 min of binding, as evidenced by the
loss of fluorescence. Further, the bacterial
killing by mast cells is a continuous process,
as evidenced by the second group of bacteria
binding at the 15 min (denoted as a solid dia-
mond) time point, indicating that mast cells
are capable of simultaneously binding one
pathogen and degrading another. Individual
bacteria (green) bound to the periphery of the
cells and were transported inward. Symbols
(asterisk and solid diamond) trace the path
of individual bacteria over time. Green  E.
coli; the time code is in the format of hr:min.
The scale bar represents 20 
m.
cells used for reconstitution resemble immature or mu- E. coli ORN103(pSH2) (Figure 7A). In contrast, no im-
provement in E. coli-induced neutrophil influx was ob-cosal-type mast cells, and they do not stain with Avidin-
FITC (Malaviya and Abraham, 1998). However, as shown served in W/Wv mice reconstituted with JAK3/ mast
cells; the markedly impaired neutrophil influx in thesein Figure 6D, W/Wv JAK3/ and W/Wv JAK3/ mast
cells exhibited strong binding to Avidin-FITC, indicating mice was virtually identical to that in JAK3-knockout
mice (Figure 7A). Taken together, these findings pro-that the bone marrow-cultured (mucosal-type) JAK3/
and JAK3/ mast cells differentiate into connective tis- vided experimental evidence that JAK3 plays a pivotal
role for mast cell TNF response to E. coli and conse-sue-type mast cells following reconstitution.
The neutrophil influx observed in W/Wv mice reconsti- quent recruitment of neutrophils to the site of infection.
In order to further evaluate the potential regulatorytuted with JAK3/mast cells was significantly improved
over that in nonreconstituted W/Wv mice and was virtu- role of JAK3 in mast cell-mediated innate immunity
against gram-negative bacteria, we next compared theally identical to the neutrophil influx in JAK3/ wild-
type mice after challenge with 4  107 type 1 fimbriated rate of bacterial clearance in JAK3/ mice to the rate
JAK3 in Bacteria-Mediated Mast Cell Response
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Figure 4. Effect of JAK3 Deficiency on Mast Cell Bactericidal Ac-
tivity
Wild-type (JAK3/) and JAK3-knockout (JAK3/) BMMC were ex-
posed to E. coli ORN103(pSH2) for 15 min to allow bacterial adher-
ence. The cells were washed to remove unbound bacteria. The
viability of bound bacteria was assessed immediately (0 min) and
60 min after the removal of unbound bacteria. The results are pre-
sented as the number of CFU/mast cell monolayer. The data points
represent the mean  SEM of triplicate values from a single exper-
iment.
of bacterial clearance in JAK3/ mice. To this end,
4  107 type 1 fimbriated E. coli ORN103(pSH2) were
injected into the peritoneal cavities of JAK3/ as well
as wild-type mice, and the number of viable bacteria in
the peritoneal lavage fluid samples was determined 2
hr later, as described in Experimental Procedures. As
shown in Figure 7B, there were approximately 3-times
more viable E. coli in JAK3/ mice than in the perito-
neum of wild-type mice (4.3  0.5, n  6 versus 1.8 
0.4, n 6, p 0.05). Thus, JAK3 deficiency is associated
with a marked impairment in bacterial clearance, remi-
niscent of the poor bacterial clearance of mast cell-
deficient mice.
Mast cell-deficient WBB6F1-W/Wv mice show mark-
edly impaired bacterial clearance, which is correctable
by adoptive transfer of mast cells from wild-type mice
(Malaviya et al., 1996). In order to further elucidate the
role of JAK3 in mast cell-mediated innate immunity
against gram-negative bacteria, we compared the rate
of bacterial clearance in mast cell-deficient mice recon- Figure 5. Effect of JAK3 Deficiency on TNFRelease and Neutrophil
Influx in Response to E. coli in Micestituted with JAK3/ mast cells (W/Wv JAK3/) from
(A) Wild-type (JAK3/) and JAK3-knockout (JAK3/) mice wereJAK3-knockout mice with that in mast cell-deficient
intraperitoneally challenged with E. coli ORN103(pSH2). After 1 hr,mice reconstituted with JAK3/ mast cells (W/Wv 
their peritoneal cavities were lavaged with 2 ml saline. The lavagesJAK3/) from wild-type mice. To this end, we chal-
were centrifuged at 200g for 10 min, and extracellular TNF levelslenged W/Wv mice, their normal congenic controls (/
in cell-free supernatants were quantitated.
mice), JAK3/ mice, JAK3/ mice, W/Wv  JAK3/ (B) JAK3/ and JAK3/ mice were challenged with E. coli, and
mice, and W/Wv JAK3/ mice with an intraperitoneal myeloperoxidase levels in the peritoneal cell pellets were quanti-
tated.inoculum of 4  107 type 1 fimbriated E. coli
The data points represent the mean  SEM values (n  4–9). AnORN103(pSH2) and evaluated the efficiency of bacterial
asterisk indicates that p  0.05, compared to wild-type controls.clearance in these mice by determining a side-by-side
comparison of the number of viable bacteria in the peri-
toneal lavage fluid samples 2 hr after the inoculation. cantly more viable bacteria than the peritoneal lavage
samples from the / congenic control mice. Similarly,As shown in Figure 7B, the peritoneal lavage samples
from W/Wv mast cell-deficient mice contained signifi- the peritoneal lavage samples from JAK3-knockout
Immunity
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Figure 6. Reconstitution of Mast Cell-Defi-
cient WBB6F1-W/Wv Mice with JAK3/ and
JAK3/ Mast Cells
(A) Bone marrow-derived mast cells from
JAK3/ and JAK3/ mice.
(B) Bone marrow mast cells from JAK3/ and
JAK3/ mice were expanded in vitro as pre-
viously described (Malaviya and Abraham,
1995; Malaviya et al., 2000). (A) JAK3/ or
JAK3/ mast cells were injected into the
peritoneal cavity (5  106 mast cells/mouse)
of WBB6F1-W/Wv (W/Wv) mice. At 10 weeks,
W/Wv mice were effectively reconstituted
with the injected mast cells, as confirmed by
cytological examination of the peritoneal la-
vage specimens from randomly picked mice.
WBB6F1-/ (/) controls (n  7) had
2.2  0.3  106 peritoneal cells/mouse, of
which 2.9  0.4  105 were mast cells. In
contrast, mast cell-deficient W/Wv mice (n 
4) had 2.6 0.2 106 peritoneal cells/mouse,
of which none was a mast cell. Mast cell-
deficient mice reconstituted with JAK3/
mast cells (W/Wv JAK3/) (n 7) had 2.6
0.3  106 peritoneal cells/mouse, of which
4.0 0.6 x105 were mast cells, and mast cell-
deficient mice reconstituted with JAK3/
mast cells (W/Wv JAK3/) (n 7) had 3.0
0.4  106 peritoneal cells/mouse, of which
2.7  0.8  105 were mast cells.
(C–D) Cytological examination of peritoneal
lavage specimens from mast cell-reconstitu-
ted W/Wv mice. The staining characteristics
and granulation of mast cells from W/Wv 
JAK3/ and W/Wv JAK3/mice were simi-
lar to those of mast cells from/mice (con-
genic controls), whereas no mast cells were
detected in the peritoneal lavage specimens
of W/Wv mice.
mice contained significantly more viable bacteria than provide direct evidence that JAK3 deficiency of mast cells
is associated with impaired bacterial clearance.the peritoneal lavage samples from the JAK3/ wild-
type controls. Impaired bacterial clearance and poor neutrophil re-
sponse in W/Wv JAK3/ mice prompted the hypothe-Peritoneal lavage samples from W/Wv JAK3/ mice
contained less bacteria than those from W/Wv mice, sis that W/Wv JAK3/mice might be more susceptible
to fatal infection with E. coli than W/Wv JAK3/ mice.indicating that JAK3/ mast cells are not devoid of
antibacterial function. This increased rate of bacterial In order to test this hypothesis, we compared the sur-
vival outcome of W/Wv JAK3/ and W/Wv JAK3/clearance in W/Wv  JAK3/ mice compared to W/Wv
mice suggests the presence of JAK3-independent sig- mice challenged with 5  107 E. coli J96. Controls in-
cluded W/Wv, /, JAK3/, and JAK3/ mice. In ac-naling pathways in mast cells, which may contribute
to bacterial clearance. Peritoneal lavage samples from cordance with previous reports (Echtenacher et al.,
1996; Malaviya et al., 1996), mast cell-deficient W/WvW/Wv JAK3/ mice also contained less bacteria than
those from JAK3/ mice, indicating that the JAK3 defi- mice exhibited worse survival than their congenic (/)
controls (20% versus 70%, p  0.03; Figure 7C). Simi-ciency of mast cells is not the sole cause of impaired
bacterial clearance in JAK3/ mice and other factors larly, JAK3/ mice showed worse survival than the cor-
responding JAK3/ control mice (17% versus 100%,such as absence of  T cells (Takano et al., 1998) likely
contribute to the observed defect. Nevertheless, there p  0.015; Figure 7C). Notably, a significantly smaller
portion of W/Wv JAK3/ mice survived the infectionwere significantly more viable bacteria in the peritoneal
lavage of W/Wv  JAK3/ mice than in the peritoneal than did the W/Wv  JAK3/ mice (37% versus 92%,
p  0.018; Figure 7C) or JAK3/ congenic control micelavage of W/Wv JAK3/ mice (Figure 7B). These results
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direct evidence that JAK3 plays a pivotal role in mast
cell-mediated innate immunity against gram-negative
bacteria.
In summary, we have shown that JAK3 plays a critical
role in mast cell-mediated bacterial clearance and neu-
trophil recruitment to the sites of bacterial infection by
regulating the release of TNF. While expanding our
knowledge regarding the role of JAK3 in host immune
defense, this study provides novel insights into the mo-




Mast cell-deficient (WBB6F1-W/Wv) and normal congenic control
(WBB6F1-/) mice were purchased from Jackson Laboratories.
Only male mice at 90 days of age or older were used in this study.
No mast cells were detected in the lung, liver, cecum, stomach, and
mesentery of W/Wv mice at any age (Galli et al., 1992). The mast
cell deficiency in W/Wv mice is due to defective hematopoietic stem
cells (Kitamura et al., 1979). Local or systemic administration of
purified peritoneal mast cells or cultured mast cells derived from
the bone marrow of / mice selectively corrects the mast cell
deficiency in W/Wv mice (Galli et al., 1992; Malaviya and Abraham,
2000; Malaviya et al., 1996). C57BL/6 and BALB/c mice (6–8 weeks
old) were purchased from Charles River Laboratories. Breeder pairs
of JAK3-knockout mice (Nosaka et al., 1995) were obtained from
Dr. J. Ihle (St. Jude Children’s Research Hospital, Memphis, TN).
JAK3 null mice (Jak3/) were generated by targeted disruption of
the Jak3 gene in embryonic stem cells (Nosaka et al., 1995). Animals
were caged in groups of five in a pathogen-free environment in
accordance with the rules and regulations of the U.S. Animal Welfare
Act and the National Institutes of Health (NIH). Animal care and
the experimental procedures were carried out in agreement with
institutional guidelines.
Reagents and Materials
Fetal bovine serum was obtained from Hyclone. Bovine serum albu-
min, toluidine blue, alcian blue, Triton X-100, and dimethyl sulph-
oxide (DMSO) were purchased from Sigma. MacConkey agar was
purchases from Difco Laboratories. Monoclonal anti-CD48 was pur-
chased from Serotec. Polyclonal anti-JAK3 antibody was purchased
from Santa Cruz Biotechnology. Avidin-FITC was purchased from
Zymed Laboratories.
Inhibitors
Figure 7. Effect of JAK3 Deficiency on Neutrophil Influx, Bacterial The synthesis and characterization of the JAK3 inhibitor WHI-P131
Clearance, and Survival of Mice in Response to E. coli (4-[4-hydroxylphenyl]-amino-6,7-dimethoxyquinazoline) and con-
Wild-type (JAK3/) and JAK3-knockout (JAK3/), W/Wv, /, trol compound WHI-P112 (4-[2,5-dibromophenyl]-amino-6,7-
W/Wv JAK3/, and W/Wv JAK3/ mice were challenged with dimethoxyquinazoline) have been described previously (Sudbeck et
4  107 E. coli ORN103(pSH2) for 2 hr as described in the legend al., 1999).
of Figure 1, and their peritoneal cavities were lavaged with 2 ml cold
saline. Bacterial Strains
(A) Myeloperoxidase levels in the cell pellets were quantitated. The E. coli strain ORN103(pSH2) is a recombinant strain containing
(B) The number of surviving bacterial colonies in lavage fluids was a plasmid, pSH2, which encodes all of the genes necessary for
quantitated. the expression of functional type 1 fimbriae (Malaviya et al., 1994;
The data points represent the mean  SEM values (n  3–11 mice). Malaviya et al., 1994). E. coli ORN103(pSH2) was cultured in Luria
An asterisk indicates that p  0.05, compared to controls. broth containing 50 
g/ml chloramphenicol. E. coli J96 was grown
(C) A table showing the effect of mast cell JAK3 deficiency on the in Luria broth (Baorto et al., 1997).
survival outcome of mice challenged with pathogenic E. coli. Mice
were challenged intraperitoneally with 5  107 E. coli J96, and their Mast Cell Cultures
mortality was recorded after 24 hr. An asterisk indicates that p  Mast cells were cultured from the bone marrow of JAK3-knockout
0.05 (chi-square test) compared to the corresponding controls (JAK3/), JAK3 wild-type (JAK3/) of C57BL/6 background, and
(CON). BALB/c mice in a medium supplemented with 25% WEHI-3 cell
supernatant for 3 weeks as previously described (Malaviya and
Abraham, 1995; Malaviya and Abraham, 2000; Malaviya et al., 2000).(37% versus 100%, p  0.05; Figure 7C). Thus, JAK3
Cell density was adjusted to 1  105 cells/ml on a weekly basis.
deficiency of mast cells adversely influences the survival After 3 weeks, bone marrow mast cells (BMMC) were characterized
outcome of mice challenged with E. coli. Taken together by staining with toluidine blue and alcian blue (Malaviya and Abra-
ham, 1995). Mast cells show metachromatic granules after stainingwith the bacterial clearance data, these results provide
Immunity
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with toluidine blue, whereas alcian blue specifically stains mast processed for publication using PhotoShop (Adobe Systems) and
archived on CD-ROM.cell granules containing chondroitin sulfate (Malaviya and Abraham,
1995).
Stimulation of Mast Cells
BMMC cultured from the bone marrow specimens of JAK3/ orConfocal Microscopy
wild-type mice were resuspended in RPMI-HEPES buffer at a cellWild-type and JAK3/ BMMC (0.1  106/ml) were cytospun onto
density of 1  106/ml. The cells were challenged with E. coliglass slides. The smears were fixed in cold methanol for 15 min,
ORN103(pSH2) at 37	C. After incubation for 60 min, the cells werefollowed by permeabilization with PBS containing 0.1% Triton
centrifuged at 200g for 10 min at 4	C. Supernatants were removedX-100. Staining of mast cells with primary and secondary antibodies,
and saved at 70	C. To study the effect of JAK3 inhibition on E.followed by confocal laser scanning microscopy, was performed as
coli-induced TNF release, mast cells were incubated with the JAK3previously described in detail (Malaviya et al., 1999). Briefly, slides
inhibitor WHI-P131 or a structurally related control compound, WHI-were incubated with an affinity-purified polyclonal anti-JAK3 anti-
P112, at the indicated concentrations or vehicle (0.1% DMSO) forbody for 40 min at 37	C. After washing with PBS-0.1% Triton X-100,
1 hr prior to bacterial challenge.slides were incubated with fluorescein-labeled secondary antibody
(Zymed) for another 40 min. Cells were washed to remove unbound
Bacterial Peritonitis Modelantibody and were visualized using a MRC 1024 laser scanning
Mice were injected with 4 107 E. coli ORN103(pSH2) intraperitone-microscope after mounting with Vectashield (Vector Laboratories).
ally as described previously (Malaviya and Abraham, 2000; Malaviya
et al., 1996). After 2 hr of incubation, all mice were sacrificed, andFlow Cytometric Analysis of CD48 Expression in Mast Cells
their peritoneal cavities were lavaged with 2 ml cold sterile salineFlow cytometric analysis of JAK3/ and JAK3/ mast cells for
(pH 7.4). The number of viable bacteria in peritoneal lavage speci-surface CD48 expression was carried out using standard methods
mens was estimated by determining the number of CFU from serial(Malaviya et al., 1999; Malaviya et al., 1999). Briefly, cells were incu-
dilutions of the cell lysates plated on MacConkey agar as describedbated with a monoclonal antibody against mouse CD48 (1:10 dilution
earlier (Malaviya and Abraham, 2000; Malaviya et al., 1996). In someof supernatant) for 1 hr at 37	C. The cells were washed thoroughly
experiments, mice were injected with 5  107 E. coli J96 intraperito-three times with sterile PBS containing 1% BSA to remove unbound
neally, and their mortality was recorded after 24 hr.antibody, labeled with FITC-conjugated goat anti-mouse antibodies
(10 
g/ml) for 30 min at 4	C, and analyzed on a FACSCalibur (Becton
Reconstitution of Mast Cell-Deficient (WBB6F1-W/Wv) Mice withDickinson).
JAK3/ and JAK3/ Mast Cells
Mast cells from the bone marrow of JAK3/ and JAK3/ miceBacterial Adherence Assay
were expanded by in vitro culture for 4 weeks and then injectedMonolayers of BMMC grown on 22  22-mm cover glasses were
intraperitoneally (5 106 cells/peritoneum) into W/Wv mice (Malaviyaincubated with type 1 fimbriated E. coli ORN103(pSH2) for 30 min as
et al., 1996; Zhang et al., 1992). After 10 weeks, W/Wv,/ (congenicdescribed previously (Malaviya et al., 1994). After unbound bacteria
controls), and W/Wv mice that were reconstituted with JAK3/were removed by washing, the monolayers were fixed in methanol
(W/Wv  JAK3/) or JAK3/ (W/Wv  JAK3/) mast cells werefor 1 min and stained with crystal violet. The number of adherent
sacrificed, and their peritoneal cells were harvested by lavage. Peri-bacteria was determined by light microscopy.
toneal cells were diluted to 1  106/ml with PBS and cytospun
(Cytospin, Shandon Southern) onto glass slides at 900 rpm for 5 minMast Cell Bactericidal Assay
(Malaviya et al., 1994). The smears were fixed in Carnoy’s fixative.Mast cells (0.4  106/ml) were seeded into the wells of a 48-well
Cytocentrifuged specimens were stained with 0.5% toluidine bluetissue culture plate and allowed to grow overnight in antibiotic-free
and examined for the presence of mast cells by light microscopy.culture medium containing 25% WEHI-3 cell supernatant. Under
these conditions, mast cells attach to the bottom of the wells and
Avidin-FITC Stainingform a monolayer. Mast cells were then exposed to 3 107 bacteria/
To assess the differentiation of mast cells in vivo, Carnoy’s fixedwell for 15 min at 4	C to allow bacterial adherence to the cells. The
cytospin smears of peritoneal cells were stained with avidin-FITCmonolayers were then washed to remove unbound bacteria, fresh
(2 
g/ml) for 2 hr at room temperature and washed three timesantibiotic-free medium was added to each well, and cells were incu-
with PBS (pH 7.4). The smears were mounted in buffered glycerolbated at 37	C for 0 or 60 min. After incubation, an equal volume of
containing 30 mM triethylenediamine (pH 8.6) (Malaviya et al., 1994).0.2% Triton X-100 was added to each well to disrupt the cells, and
viable bacteria were quantitated by determining the number of CFU
Measurement of Neutrophil Influxfrom serial dilutions of the cell lysates plated on MacConkey agar
Neutrophil influx into the mouse peritoneum was evaluated by mea-as described earlier (Malaviya et al., 1996; Malaviya et al., 1994).
suring myeloperoxidase activity colorimetrically in the cell lysates
of peritoneal lavage specimens (Malaviya and Abraham, 2000; Ma-Confocal Imaging of Bacterial Phagocytosis by Live Mast Cells
laviya et al., 1996).Vitronectin-coated cover slips (40 mm2 and 1.5 mm thick) were
seeded with BMMC of wild-type mice or JAK3/ mice. Cells were
TNF Release Assaysallowed to adhere to cover slips overnight at 37	C in a humidified
TNF levels were estimated in cell-free supernatants using standardtissue culture incubator with 95% air and 5% CO2. The BMMC-
cytotoxicity assays (Malaviya et al., 1999; Malaviya et al., 1999).seeded cover slips were placed into a FCS2 chamber (Bioptechs).
The FCS2 is a cell culture system for microscopy that allows for
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